Major grant awarded to research ways to
prevent heart failure
28 February 2013
Researchers at the University of Hull and Hull York Medical
School have won a grant for nearly £600,000 to identify new ways of
predicting which patients are at risk of heart failure – and to
help find treatments to prevent it.
The grant, made by the European Commission under the FP7
Programme, is worth £580,480 to the Department of Cardiology over
the next six years. This is the latest in a series of major grants
from the European Commission to the department for research into
heart failure - one of Britain’s most common and dangerous diseases
– which together are worth approximately £1.5 million.
< Professor John Cleland
Hull’s Department of Cardiology joins a Consortium led by
Professor Faiez Zannad of Inserm, University of Lorraine and the
Centre Hospitalier Universitaire (University Hospital Centre),
Nancy, France that will carry out this research. Partner
organisations (nineteen Universities, Hospitals and research
organisations) come from nine European countries and the United
States of America.
The HOMAGE (Heart OMics in AGEing) project, which takes ‘an
ounce of prevention is worth a pound in cure’ as its prime focus,
will identify new blood tests that determine the risk of developing
heart failure and then look for novel treatments that can be
targeted specifically at those at high risk in order to prevent its
Professor John Cleland (University of Hull and Honorary
Consultant in Cardiology at the Hull and East Yorkshire Hospitals
NHS Trust), who is widely regarded as one of the world’s leading
researchers into heart failure, will lead the research.
Professor Cleland said: “Heart failure is increasingly common in
the UK. About one in every 30 adults in Hull has some evidence of
heart failure. In Britain, during 2011, there were almost 400,000
admissions with heart failure and about 4 million NHS bed-days were
required to manage the problem.
“Rates have been rising steadily for the last decade. Managing
heart failure well with modern treatments is often very successful
but it is complex and there are far too few experts compared to the
size of the problem.
“The aim of this research is to try to identify people at risk
before they get into trouble and specifically target them with
relatively simple treatments that family doctors can easily use to
prevent or at least delay the onset of heart failure.”
Page last updated by Andrea Luquesi on
For media enquiries, please contact Claire Hughes on
01482 465268 or 07703 888622.
About Prof John Cleland
Professor John G F
Cleland, MD, PhD, FRCP, FESC, FACC, (University of Hull and
Honorary Consultant in Cardiology at the Hull and East Yorkshire
Hospitals NHS Trust) leads the research focussing on new treatments
to delay or prevent the development of heart failure. Professor
Cleland is widely regarded as one of the world’s leading
researchers into heart failure.